CoChat

Predicting Macro- and Microvascular Complications in Type 2 Diabetes

Open access
Tanaka, Shiro, Tanaka, Sachiko, Iimuro, Satoshi, Yamashita, Hidetoshi, Katayama, Shigehiro, Akanuma, Yasuo, Yamada, Nobuhiro, Araki, Atsushi, Ito, Hideki, Sone, Hirohito, Ohashi, Yasuo, for the Japan Diabetes Complications Study Group and the Japanese Elderly Diabetes Intervention Trial Group · 2013 · Diabetes Care
Cited by 128

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To develop and validate a risk engine that calculates the risks of macro- and microvascular complications in type 2 diabetes. RESEARCH DESIGN AND METHODS: We analyzed pooled data from two clinical trials on 1,748 Japanese type 2 diabetic patients without diabetes complications other than mild diabetic retinopathy with a median follow-up of 7.2 years. End points were coronary heart disease (CHD), stroke, noncardiovascular mortality, overt nephropathy defined by persistent proteinuria, and progression of retinopathy. We fit a multistate Cox regression model to derive an algorithm for prediction. The predictive accuracy of the calculated 5-year risks was cross-validated. RESULTS: Sex, age, HbA1c, years after diagnosis, BMI, systolic blood pressure, non-HDL cholesterol, albumin-to-creatinine ratio, atrial fibrillation, current smoker, and leisure-time physical activity were risk factors for macro- and microvascular complications and were incorporated into the risk engine. The observed-to-predicted (O/P) ratios for each event were between 0.93 and 1.08, and Hosmer-Lemeshow tests showed no significant deviations between observed and predicted events. In contrast, the UK Prospective Diabetes Study (UKPDS) risk engine overestimated CHD risk (O/P ratios: 0.30 for CHD and 0.72 for stroke). C statistics in our Japanese patients were high for CHD, noncardiovascular mortality, and overt nephropathy (0.725, 0.696, and 0.767) but moderate for stroke and progression of retinopathy (0.636 and 0.614). By combining macro- and microvascular risks, the classification of low- and high-risk patients was improved by a net reclassification improvement of 5.7% (P = 0.02). CONCLUSIONS: The risk engine accurately predicts macro- and microvascular complications and would provide helpful information in risk classification and health economic simulations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-0958

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 128

Metadata

Authors
Tanaka, S., Tanaka, S., Iimuro, S., Yamashita, H., Katayama, S., Akanuma, Y., Yamada, N., Araki, A., Ito, H., Sone, H., Ohashi, Y., & for the Japan Diabetes Complications Study Group and the Japanese Elderly Diabetes Intervention Trial Group
Venue
Diabetes Care
Published
2013-04-13
Volume
36
Issue
5
Pages
1193-1199
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2113386595
Cited by
128
References
12
FWCI
7.08
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting Macro- and Microvascular Complications in Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc12-0958
The paper
Tanaka, S., Tanaka, S., Iimuro, S., Yamashita, H., Katayama, S., Akanuma, Y., Yamada, N., Araki, A., Ito, H., Sone, H., Ohashi, Y., & for the Japan Diabetes Complications Study Group and the Japanese Elderly Diabetes Intervention Trial Group. (2013). Predicting Macro- and Microvascular Complications in Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc12-0958

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.